Invenomic Capital Management’s Albany International AIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-386,053
Closed -$19.6M 151
2025
Q4
$19.6M Buy
386,053
+62,058
+19% +$3.21M 0.91% 37
2025
Q3
$17.3M Buy
+323,995
New +$20.6M 0.84% 39
2025
Q2
Sell
-70,611
Closed -$4.87M 151
2025
Q1
$4.87M Sell
70,611
-74,231
-51% -$5.77M 0.25% 115
2024
Q4
$11.6M Buy
+144,842
New +$11.4M 0.55% 55

Other funds holding AIN

Invenomic Capital Management's AIN Position: Q1 2026 in Review

Invenomic Capital Management sold out of Albany International (AIN) in Q1 2026, closing a stake of 386,053 shares — an estimated $19.6M sold.

Invenomic Capital Management first reported a position in AIN in Q4 2024 and held it in 4 quarters. The position peaked at $19.6M in Q4 2025. 237 funds tracked by Wall St. Rank hold AIN as of Q1 2026.

  • Invenomic Capital Management reported no remaining Albany International position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 386,053 Albany International shares in Q1 2026, an estimated $19.6M.
  • Invenomic Capital Management first reported a position in Albany International in Q4 2024 and held it in 4 quarters.
  • Invenomic Capital Management's Albany International position peaked at $19.6M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Albany International as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.